EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Fibroblast activation protein inhibitor PET for monitoring fibrotic diseases

Rikke Helin Johnsen, Katja Bjerregaard Christensen, Saher B Shaker, Jann Mortensen, Christoffer Tandrup Nielsen

Ugeskrift for Læger · 2025

DOI: 10.61409/v04250306 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Ugeskrift for Læger, 2025. Verfasst von Rikke Helin Johnsen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Lunge- og Infektionsmedicinsk Afdeling, Københavns Universitetshospital - Nordsjællands Hospital. Hauptthemen laut MEDLINE: Positron-Emission Tomography, Serine Endopeptidases, Gelatinases. Die Arbeit nennt 29 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Fibroblast activation protein inhibitor (FAPI) PET was initially developed for cancer diagnostics; however, studies suggest that FAPI PET is a promising modality in various fibrotic diseases, including interstitial lung disease, fibrotic myocardial diseases, and rheumatic diseases such as rheumatoid arthritis, IgG4-related disease, and systemic scleroderma. There are limited studies on the subject, but this review finds that FAPI PET can accurately and specifically visualise active fibrosis and holds potential for monitoring treatment response and differentiation between inflammation and fibrosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Positron-Emission TomographySerine EndopeptidasesGelatinasesHumansFibrosisLung Diseases, InterstitialScleroderma, SystemicEndopeptidasesRheumatic DiseasesArthritis, RheumatoidImmunoglobulin G4-Related DiseaseCardiomyopathiesMembrane ProteinsFibroblast Activation Protein Alpha

Substanzen

Serine EndopeptidasesGelatinasesEndopeptidasesMembrane ProteinsFibroblast Activation Protein Alpha

Autor:innen und Institutionen

  • Lunge- og Infektionsmedicinsk Afdeling, Københavns Universitetshospital - Nordsjællands Hospital.
  • Lungemedicinsk Sektion, Afdeling for Medicinske Sygdomme, Københavns Universitetshospital - Herlev og Gentofte Hospital.
  • Afdeling for Klinisk Fysiologi og Nuklearmedicin, Københavns Universitetshospital - Rigshospitalet.
  • Afdeling for Rygkirurgi, Led- og Bindevævssygdomme, Københavns Universitetshospital - Rigshospitalet.

Zitieren

APA

Johnsen, R. H., Christensen, K. B., Shaker, S. B., Mortensen, J., & Nielsen, C. T. (2025). Fibroblast activation protein inhibitor PET for monitoring fibrotic diseases. Ugeskrift for Læger. https://doi.org/10.61409/v04250306

Vancouver

Johnsen RH, Christensen KB, Shaker SB, Mortensen J, Nielsen CT. Fibroblast activation protein inhibitor PET for monitoring fibrotic diseases. Ugeskrift for Læger. 2025. doi:10.61409/v04250306

BibTeX
@article{Johnsen2025,
  author = {Johnsen, Rikke Helin and Christensen, Katja Bjerregaard and Shaker, Saher B and Mortensen, Jann and Nielsen, Christoffer Tandrup},
  title = {Fibroblast activation protein inhibitor PET for monitoring fibrotic diseases},
  journal = {Ugeskrift for Læger},
  year = {2025},
  doi = {10.61409/v04250306}
}
Kostenlos starten →